Peanut allergy in children has risen roughly threefold over the past two decades, reaching somewhere between 1 and 2 percent of kids in Western countries, and researchers now believe no single cause is responsible. Instead, several forces that changed in parallel over the same period appear to have converged: shifts in how and when babies are exposed to peanut protein, changes in the diversity of gut bacteria, genetic vulnerabilities in the skin barrier, and even the way peanuts are cooked. Understanding which of these threads matters most is still an active area of research, but the picture that has emerged in the last ten years is far more detailed than the vague “allergies are on the rise” narrative most parents hear.
How Much the Numbers Have Actually Changed
The scale of the increase depends on which study you look at and how allergy is defined, but the trend is consistent. A white paper reviewing international data reported that peanut allergy prevalence climbed about 3.5-fold over two decades, landing at roughly 1.4 to 2 percent in both Europe and the United States.1PubMed Central. White paper on peanut allergy – part 1: Epidemiology, burden of disease, health economic aspects In one well-tracked group of British children, peanut sensitization tripled from about 1 percent to 3.3 percent between the late 1980s and mid-1990s cohorts, then dipped slightly in a third cohort studied a few years later.2PubMed. Time trends in the prevalence of peanut allergy: three cohorts of children from the same geographical location in the UK That partial leveling-off is encouraging, but the allergy rate never returned to where it started, and in many regions it has continued to climb.
One important caveat: better awareness and more frequent testing may explain part of the statistical rise. Parents today are far more likely to seek allergy evaluation for a child who reacts to peanut butter than parents were in the 1980s. Still, studies that used consistent methods across cohorts, including skin-prick testing and oral food challenges, confirm that the increase is real and not just a diagnostic artifact.3Journal of Allergy and Clinical Immunology. Rising prevalence of allergy to peanut in children: Data from 2 successive cohorts
The Dual Allergen Exposure Idea
For years, pediatricians told parents of high-risk babies to delay introducing peanut. The logic seemed straightforward: keep the allergen away until the immune system matures. That advice turned out to be exactly backwards, and understanding why requires a concept called the dual allergen exposure hypothesis. In short, the immune system can encounter peanut protein through two very different routes, and each route pushes the immune response in a different direction.
When peanut protein enters the body through the gut, especially early in life, the immune system tends to learn to tolerate it. But when peanut protein lands on inflamed or broken skin, the immune system is more likely to treat it as a threat and mount an allergic response.4PubMed Central. Skin and oral intervention for food allergy prevention based on dual allergen exposure hypothesis A baby with eczema whose skin is cracked and leaky might be absorbing trace peanut protein from the household environment well before anyone puts a spoonful of peanut butter in front of them. If the first meaningful encounter with peanut happens through damaged skin rather than through the digestive tract, the stage is set for allergy instead of tolerance.
This framework explains a pattern that puzzled researchers for a long time: children with eczema are dramatically more likely to develop peanut allergy. It is not that eczema and peanut allergy share some mysterious link. The eczema literally creates a doorway for sensitization.5PubMed. The role of environmental exposure to peanut in the development of clinical allergy to peanut
Why Skin Genes Matter
A protein called filaggrin is one of the main structural components that keeps the outer layer of skin intact and waterproof. Some children carry mutations in the filaggrin gene that weaken this barrier, making their skin drier and more prone to cracking. These mutations are surprisingly common, affecting a meaningful fraction of the population in European-descent groups, and they turn out to be a strong, independent risk factor for peanut allergy.6PubMed Central. Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy
The risk is not just about having a leaky skin barrier in general. It interacts with how much peanut protein is floating around in the child’s environment. In one study, children with filaggrin mutations who lived in homes with higher levels of peanut protein in house dust had more than six times the odds of becoming sensitized to peanut and more than three times the odds of developing clinical peanut allergy compared to children with normal filaggrin genes.7PubMed Central. Peanut allergy: Effect of environmental peanut exposure in children with filaggrin loss-of-function mutations Children without those mutations were far less affected by the same household peanut exposure. Genetics and environment are not separate explanations competing with each other here; they are two halves of the same mechanism.
Peanut Protein in the Home
If you eat peanut butter sandwiches regularly, peanut protein ends up in your house dust. This is not a trivial amount, and it does not stay on the kitchen counter. Peanut allergens have been detected on surfaces throughout homes, in bedding, and in airborne dust. For a baby crawling on the floor with eczema-affected skin, this ambient exposure can be a route of sensitization long before the child is old enough to eat solid food.
Research in mice has shown that inhaling low levels of peanut protein combined with indoor dust, but neither alone, was enough to trigger peanut-specific allergic antibodies and even anaphylaxis on later challenge.8PubMed Central. Indoor dust acts as an adjuvant to promote sensitization to peanut through the airway The dust itself seems to act as an immune-boosting substance that amplifies the allergic response to the peanut protein. While mouse studies do not directly prove the same thing happens in human infants, they support the observation that environmental peanut exposure in the home is a genuine factor in allergy development, not just a background curiosity.
The Gut Microbiome Connection
Babies born today encounter a different microbial world than babies born fifty years ago. Higher rates of cesarean delivery, more antibiotic use in early life, smaller families, less outdoor and animal exposure, and more sanitized living environments all shape which bacteria colonize a baby’s gut in those first critical months. The so-called hygiene hypothesis, now increasingly framed as the “microbiome hypothesis,” proposes that this altered microbial exposure is one reason allergic diseases of all kinds have become more common in industrialized countries.
For peanut allergy specifically, a longitudinal study tracking children from infancy to mid-childhood found that infants who went on to develop peanut allergy had lower gut microbiome diversity than those who did not. The study also identified changes in specific bacterial groups and metabolites associated with allergy development, including shifts in certain Clostridium and Bifidobacterium species and changes in short-chain fatty acid levels like butyrate over time.9PubMed Central. Longitudinal dynamics of the gut microbiome and metabolome in peanut allergy development Butyrate, produced by certain gut bacteria, plays a role in training the immune system to tolerate harmless proteins rather than attack them. A gut environment producing less of it in infancy could plausibly tip the balance toward allergic sensitization.
This does not mean that hand sanitizer is causing peanut allergies, which is the oversimplified version of the hygiene hypothesis that circulates online. The relationship between microbial exposure and immune development is subtler than “clean equals allergic.” But the broad trend of reduced microbial diversity in industrialized populations aligns with the rise in allergic disease across the board, not just peanut allergy.
How Peanuts Are Cooked
Here is a genuinely surprising piece of the puzzle. In countries where peanuts are primarily boiled, like many parts of East and Southeast Asia, peanut allergy rates have historically been lower than in countries where peanuts are dry-roasted, like the United States, the United Kingdom, and Australia. Researchers have investigated whether the cooking method itself changes how allergenic the peanut proteins are, and the answer appears to be yes.
Roasting peanuts at high temperatures modifies key allergen proteins, particularly Ara h 1 and Ara h 2, in ways that make them more resistant to digestion and, in some cases, more potent at triggering immune cells.10PubMed Central. Boiling and roasting treatment affecting the peanut allergenicity Boiled peanuts, by contrast, show lower allergic reactivity. One study found that the antibody-binding capacity of boiled peanut extracts was about half that of raw or roasted extracts, partly because boiling causes some of the smaller allergenic proteins to leach out into the cooking water.11PubMed. Influence of thermal processing on the allergenicity of peanut proteins Roasting, meanwhile, creates structural changes in Ara h 1 that produce compact, tightly folded protein clumps that retain their ability to bind allergic antibodies, while boiling creates looser, rod-like aggregates with reduced allergenic activity.12PubMed. Boiling peanut Ara h 1 results in the formation of aggregates with reduced allergenicity
This does not mean that switching to boiled peanuts would prevent allergies in an individual child. The cooking-method difference is one factor among many, and it likely contributes at a population level rather than as a decisive individual-level cause. But it helps explain why peanut allergy prevalence is not uniform across cultures, even in places with similar levels of peanut consumption.
Early Introduction Changed Everything
The single most practice-changing study in peanut allergy research was the LEAP trial, published in 2015. Researchers enrolled over 600 infants who were at high risk for peanut allergy because they already had severe eczema, egg allergy, or both. Half were assigned to eat peanut-containing foods regularly starting between four and eleven months of age; the other half avoided peanut entirely until age five.
The results were dramatic. Among babies who initially showed no sensitization on skin testing, peanut allergy at age five was about 14 percent in the avoidance group versus roughly 2 percent in the group that ate peanut early. Among babies who already showed some sensitization, allergy rates were about 35 percent in the avoidance group versus about 11 percent in the consumption group.13PubMed Central. Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy Early oral exposure did not just reduce the risk a little. It slashed it by more than 80 percent in the lower-risk group.
This trial effectively reversed international feeding guidelines. Before LEAP, most allergy organizations recommended delaying peanut introduction. Now they recommend the opposite: introducing peanut-containing foods early, typically around four to six months, especially for high-risk infants. The shift in guidance has been one of the most rapid about-faces in pediatric nutrition in recent memory, and there is real hope that the generation of babies raised on the new guidelines will show lower allergy rates as they grow up.
What About Eating Peanuts During Pregnancy and Breastfeeding
A natural follow-up question: if early oral exposure protects the baby, does maternal peanut consumption during pregnancy or breastfeeding do the same? For years, some guidelines told pregnant and nursing women to avoid peanuts, mirroring the now-discredited advice given for infants.
Current evidence is clear that there is no benefit to maternal peanut avoidance during pregnancy or breastfeeding as a strategy for preventing allergy in the child. There is also emerging, though not yet definitive, evidence suggesting that eating peanut during breastfeeding, combined with early peanut introduction to the infant, may actually have a protective effect.14PubMed. Prevention of food allergy in infancy: the role of maternal interventions and exposures during pregnancy and lactation The hypothesis is that small amounts of peanut protein passed through breast milk could help prime the infant’s immune system toward tolerance, especially when paired with direct oral exposure. This is an area where research is still catching up to the hypothesis, but at a minimum, pregnant and breastfeeding women should not restrict peanuts out of fear of causing allergy in their baby.
The Urban-Rural Gap and Geography
Peanut allergy is not equally common everywhere. It is far more prevalent in urban, industrialized settings than in rural ones, and rates differ significantly between countries. Data from South Africa illustrate this starkly: in urban South African children, peanut allergy prevalence was about 0.8 percent, which is lower than typical Western figures but far higher than what is found in rural populations within the same country.15PubMed. Rural and urban food allergy prevalence from the South African Food Allergy study This urban-rural gradient mirrors patterns seen for other allergic diseases and reinforces the idea that environmental and lifestyle factors, not just genetics, are driving the epidemic.
What exactly about urban life increases risk is hard to pin down to a single variable. It could be any combination of lower microbial diversity, different dietary patterns, higher rates of cesarean delivery, greater antibiotic exposure, and less contact with farm animals and soil. These factors are deeply intertwined and difficult to separate in observational studies. But the geographic pattern is one of the strongest clues that the peanut allergy rise is fundamentally an environmental and lifestyle phenomenon, not a genetic shift in the population.
Better Diagnostics, Not Just More Allergies
Part of understanding why peanut allergy seems so common is recognizing that diagnostic tools have improved substantially. A child who tests positive for peanut-specific antibodies on a blood test might not actually be clinically allergic. Sensitization, meaning the immune system has produced antibodies against peanut protein, does not always translate into a real allergic reaction when the food is eaten. This mismatch has historically led to overdiagnosis, where children are labeled peanut-allergic based on blood tests alone and placed on unnecessarily restrictive diets.
Newer testing approaches have improved accuracy. Measuring antibodies to specific peanut protein components, particularly Ara h 2, is a better predictor of genuine clinical allergy than older whole-peanut blood tests. A meta-analysis of pediatric studies found that Ara h 2 testing had roughly 83 percent sensitivity and 84 percent specificity for diagnosing true peanut allergy, substantially outperforming antibody tests targeting other peanut components.16PubMed. Accuracy of component-resolved diagnostics in peanut allergy: Systematic literature review and meta-analysis Using this more targeted test can also significantly reduce the need for oral food challenges, which are the gold standard but expensive and anxiety-inducing for families.17PubMed Central. Diagnostic accuracy of Ara h 2 for detecting peanut allergy in children
Better diagnostics cut both ways when it comes to prevalence numbers. On one hand, improved testing catches real cases that would have been missed decades ago. On the other, it may also more accurately exclude children who are sensitized but tolerant, potentially preventing some of the overdiagnosis that inflated earlier estimates. The net effect on reported prevalence is hard to quantify, but it is worth remembering that “more kids diagnosed” and “more kids actually allergic” are not identical statements.
Cross-Reactivity With Other Legumes
Peanuts are not nuts. They are legumes, in the same botanical family as lentils, chickpeas, soybeans, and lupine. Because these plants share some protein structures, the immune system of a peanut-allergic child can sometimes recognize other legumes as threats too. Among peanut-allergic children in one study, about 64 percent showed sensitization to at least one other legume, with fenugreek, lentil, soy, and lupine being the most common. About 28 percent of those sensitized children had a confirmed clinical allergy to another legume, and half of those reactions were severe.18PubMed Central. Relevance of sensitization to legumes in peanut‐allergic children
Atopic dermatitis, the most common form of childhood eczema, was a major risk factor for cross-allergy to tree nuts and other legumes in peanut-allergic children.19PubMed. Phenotypical characterization of peanut allergic children with differences in cross-allergy to tree nuts and other legumes This pattern loops back to the skin barrier story: a child whose eczema allowed initial sensitization to peanut through the skin may have been sensitized to structurally similar legume proteins through the same route. For families managing peanut allergy, awareness of potential legume cross-reactivity matters practically, since lupine flour, for instance, is increasingly used in European baked goods and can trigger reactions in peanut-allergic individuals who have never knowingly eaten lupine before.
Treatment Is Advancing Quickly
For decades, the only management option for peanut allergy was strict avoidance plus carrying an epinephrine auto-injector. That has started to change. Oral immunotherapy, which involves giving tiny, gradually increasing doses of peanut protein under medical supervision, can raise the amount of peanut a child can tolerate before reacting. The treatment works by gradually shifting the immune response: allergic antibodies eventually decrease below baseline levels, blocking antibodies rise, and the immune cells that drive allergic reactions become less responsive over the course of treatment.20PubMed Central. Mechanisms of oral immunotherapy
Recent research using single-cell analysis of immune cells from patients in a peanut oral immunotherapy trial has shown that successful treatment is associated with a decline in the allergy-driving T cell populations and an expansion of cell types linked to immune tolerance. Patients who achieved sustained unresponsiveness, meaning they could eat peanut without reacting even after stopping therapy, had distinct immune profiles at baseline and after treatment compared to those who did not.21PubMed Central. Peanut allergy oral immunotherapy drives single-cell multi-omic changes in peanut-reactive T cells associated with sustained unresponsiveness This kind of detailed immune profiling could eventually help doctors predict which children are most likely to benefit from oral immunotherapy before they start.
Another promising approach uses omalizumab, an injectable antibody that blocks IgE, the antibody class responsible for allergic reactions. In a recent trial of people with multiple food allergies, about two-thirds of those treated with omalizumab could tolerate a significantly higher amount of peanut protein after 16 weeks, compared to only 7 percent on placebo.22PubMed Central. Omalizumab for the Treatment of Multiple Food Allergies Omalizumab has also been studied as a way to speed up oral immunotherapy, allowing faster dose increases with fewer reactions during treatment.23PubMed Central. Omalizumab facilitates rapid oral desensitization for peanut allergy Neither approach is a cure, and both require medical oversight, but they represent a real shift from decades of “just avoid it.”
The Emotional Weight on Families
The anxiety of managing a child’s peanut allergy is easy to underestimate if you have not lived it. In a large survey of peanut-allergic individuals and their caregivers across the UK and Ireland, about 79 percent reported at least moderate levels of uncertainty about their safety, 71 percent reported significant stress, and 75 percent reported feeling anxious at least moderately often. Two-thirds said peanut allergy required at least a moderate amount of extra daily planning, and that figure rose to 78 percent for special occasions and holidays.24PLOS ONE. Allergy to Peanuts imPacting Emotions And Life (APPEAL): The impact of peanut allergy on children, teenagers, adults and caregivers in the UK and Ireland Children with more severe allergy and a history of reactions carried a particularly high psychosocial burden.25PubMed. Peanut allergy impact on productivity and quality of life (PAPRIQUA): Caregiver-reported psychosocial impact of peanut allergy on children
School lunchrooms, birthday parties, playdates, restaurant meals, and air travel all become potential minefields. The constant vigilance required takes a real toll on children’s social development and on parents’ mental health. This emotional dimension is part of why the question “why are so many kids allergic?” carries an urgency that goes beyond academic curiosity. Every percentage-point increase in prevalence translates to thousands more families navigating that daily stress, and every advance in prevention or treatment has outsized practical impact on quality of life.